July 26, 2023

Focus on the PARITY Trial, with special guest Michelle Ghert, MD, FRCSC

21 minutes

In this episode, Marc and Mo are joined by special guest Michelle Ghert, MD, FRCSC (Professor of Surgery at McMaster University and President of the Musculoskeletal Tumor Society) in a discussion of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) study that appeared in JAMA as well as the related JBJS supplement focusing on secondary analytic questions.

Links:

PARITY Supplement in JBJS: https://bit.ly/47fEkqH

Editorial focusing on PARITY: https://bit.ly/44ExN6Z

Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Investigators; Ghert M, Schneider P, Guyatt G, Thabane L, Vélez R, O'Shea T, Randall RL, Turcotte R, Wilson D, Wunder JS, Baptista AM, Cheng EY, Doung YC, Ferguson PC, Giglio V, Hayden J, Heels-Ansdell D, Khan SA, Sampath Kumar V, McKay P, Miller B, van de Sande M, Zumárraga JP, Bhandari M. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncol. 2022 Mar 1;8(3):345-353. doi: 10.1001/jamaoncol.2021.6628. PMID: 34989778; PMCID: PMC8739829. https://bit.ly/3K7MG8S

Subspecialties:

Infection

Oncology

Orthopaedic Essentials

...more